Functional consequences of toll-like receptor 4 polymorphisms

被引:203
|
作者
Ferwerda, Bart [1 ,2 ]
McCall, Matthew B. B. [1 ,3 ]
Verheijen, Karlijn [1 ,2 ]
Kullberg, Bart-Jan [1 ,2 ]
van der Ven, Andre J. A. M. [1 ,2 ]
Van der Meer, Jos W. M. [1 ,2 ]
Netea, Mihai G. [1 ,2 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Med 463, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Ctr Infect Dis, Nijmegen, Netherlands
[3] Univ Nijmegen, Dept Parasitol, Nijmegen, Netherlands
关键词
D O I
10.2119/2007-00135.Ferwerda
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toll-like receptor 4 (TLR4) is an important pathogen recognition receptor that recognizes mainly lipopolysaccharide (LPS) of Gram-negative bacteria, but also structures from fungal and mycobacterial pathogens, as well as endogenous ligands. Two nonsynonymous polymorphisms of TLR4, Asp299Gly and Thr399IIe, have been suggested to alter the function of the receptor. Some, but not all, studies have proposed that these polymorphisms lead to reduced cytokine response and increased susceptibility to Gram-negative infections. In this review, we compare studies that assessed the effect of the Asp299Gly and Thr399IIe polymorphisms on susceptibility to Gram-negative infections and examine the phenotypic consequences of these polymorphisms. In addition, we review the geographical distribution of TLR4 polymorphisms and present a model for evolutionary pressures on the TLR4 genetic make-up.
引用
收藏
页码:346 / 352
页数:7
相关论文
共 50 条
  • [1] Functional Consequences of Toll-like Receptor 4 Polymorphisms
    Bart Ferwerda
    Matthew B. B. McCall
    Karlijn Verheijen
    Bart-Jan Kullberg
    André J. A. M. van der Ven
    Jos W. M. Van der Meer
    Mihai G. Netea
    Molecular Medicine, 2008, 14 : 346 - 352
  • [2] Toll-like receptor 4 polymorphisms and atherogenesis
    Beutler, B
    Beutler, E
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (24): : 1978 - 1979
  • [3] Toll-like receptor 4 polymorphisms and atherogenesis
    Kiechl, S
    Lorenz, E
    Reindl, M
    Wiedermann, CJ
    Oberhollenzer, F
    Bonora, E
    Willeit, J
    Schwartz, DA
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (03): : 185 - 192
  • [4] Toll-like Receptor 4 Polymorphisms and Aspergillosis
    Levitz, Stuart M.
    Shoham, Shmuel
    Cleary, John D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (06): : 634 - 634
  • [5] Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease
    Moens, Leen
    Verhaegen, Jan
    Pierik, Marie
    Vermeire, Severine
    De Boeck, Kris
    Peetermans, Willy E.
    Bossuyt, Xavier
    MICROBES AND INFECTION, 2007, 9 (01) : 15 - 20
  • [6] Toll-like receptor 4 polymorphisms and atherogenesis - Reply
    Kiechl, S
    Willeit, J
    Schwartz, DA
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (24): : 1979 - 1980
  • [7] Toll-like receptor 4 polymorphisms and ankylosing spondylitis
    R Adam
    JA Gracie
    RD Sturrock
    Arthritis Research & Therapy, 7
  • [8] Toll-like receptor 4 polymorphisms and ankylosing spondylitis
    Adam, R.
    Gracie, J. A.
    Sturrock, R. D.
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S59 - S59
  • [9] Toll-like receptor (TLR) 4 polymorphisms and COPD
    Sabroe, I
    Whyte, MKB
    Wilson, AG
    Dower, SK
    Hubbard, R
    Hall, I
    THORAX, 2004, 59 (01) : 81 - 81
  • [10] Lack of association between Toll-like receptor 2 and Toll-like receptor 4 polymorphisms and atopic eczema
    Weidinger, Stephan
    Novak, Natalija
    Klopp, Norman
    Baurecht, Hansjoerg
    Wagenpfeil, Stefan
    Rummler, Lars
    Ring, Johannes
    Behrendt, Heidrun
    Illig, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (01) : 277 - 279